Global X HealthTech ETF (NASDAQ:HEAL – Get Free Report) was the recipient of a significant decline in short interest in the month of October. As of October 15th, there was short interest totaling 1,958 shares, a decline of 45.6% from the September 30th total of 3,598 shares. Currently, 0.2% of the company’s shares are sold short. Based on an average daily volume of 4,540 shares, the days-to-cover ratio is currently 0.4 days.
Institutional Investors Weigh In On Global X HealthTech ETF
Institutional investors have recently added to or reduced their stakes in the business. Royal Bank of Canada raised its position in shares of Global X HealthTech ETF by 39.4% in the 1st quarter. Royal Bank of Canada now owns 2,603 shares of the company’s stock valued at $62,000 after purchasing an additional 736 shares during the last quarter. Farther Finance Advisors LLC increased its holdings in shares of Global X HealthTech ETF by 4.3% in the third quarter. Farther Finance Advisors LLC now owns 23,037 shares of the company’s stock valued at $680,000 after purchasing an additional 950 shares during the period. Finally, C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors increased its holdings in shares of Global X HealthTech ETF by 28.3% in the third quarter. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors now owns 195,122 shares of the company’s stock valued at $5,758,000 after purchasing an additional 43,075 shares during the period.
Global X HealthTech ETF Stock Down 2.6%
HEAL stock traded down $0.81 during trading on Friday, hitting $30.70. The company had a trading volume of 6,719 shares, compared to its average volume of 10,514. The firm has a market capitalization of $34.69 million, a P/E ratio of 42.80 and a beta of 1.13. Global X HealthTech ETF has a 52-week low of $23.00 and a 52-week high of $32.15. The company has a 50 day simple moving average of $29.68 and a 200-day simple moving average of $27.31.
Global X HealthTech ETF Company Profile
An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.
Featured Articles
- Five stocks we like better than Global X HealthTech ETF
- Starbucks Says Its Turnaround Is DoneāThe Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Global X HealthTech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global X HealthTech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
